S. 2292: Over-the-Counter Monograph Drug User Fee Amendments

S. 2292 is a federal bill in the 119th Congress. Drug manufacturers currently pay fees to the Food and Drug Administration to help review over-the-counter medications, but that funding authority was set to expire. This bill extends those fee collections through fiscal year 2030, ensuring the agency has… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.